Merck
CN
HomeHematologyBlood Basics

Blood Basics

Physical Properties of Blood and Plasma

How much blood is in the human body?

The average adult has a blood volume of approximately 5 liters, which comprises about 8% of the body's weight. The osmolality (concentration of solutes in water) of blood is 275-295 milliosmoles per kg.

What is blood plasma?

Plasma is the straw-colored liquid component of blood. It is a protein-salt solution and acts as a suspension for red and white blood cells and platelets.

What is plasma made of?

Plasma constitutes approximately 55% of blood's volume and is comprised of:

  • 90% Water
  • 8% Protein
  • 0.9% Inorganic Salts
    • Sodium 135-146 mM
    • Potassium 3.5-5.2 mM
    • Calcium 2.1-2.7 mM
    • Carbonate 23-31 mM
    • Phosphate 0.7-1.4 mM
  • 1.1% of organic substances

The protein content of plasma

It is estimated that plasma may contain as many as 40,000 different proteins from about 500 gene products. Approximately 1,000 proteins have been detected.

Plasma contains three major types of proteins: albumins, globulins, and fibrinogens.

  • Albumins are the most abundant protein group present in blood plasma.
  • Globulins can further be divided into α1, α2, β1, β2, and γ-globulins.
  • Fibrinogen is the plasma protein coagulation factor.1
  • The plasma proteins can be classified by their functionalities into three classes: proteolytic enzymes, protease inhibitors, and carrier proteins.
  • Plasma contains 50-70 mg of protein per ml
    • Approx. 70% Albumin (35-50 mg/ml)
    • Approx. 10% IgG (5-7 mg/ml)

Blood Composition on the Cellular Level

For every 600 red blood cells, there are approximately 40 platelets and one white cell.

Red Blood Cells (Erythrocytes)

  • Typically 4-8 x 106 cells per µl
  • Composed approx 90% hemoglobin
  • RBCs have a life-span of approx. 120 days before they are removed by the spleen
Blood Composition

Figure 1.Blood Composition

Platelets (Thrombocytes)

  • Typically 150,000-350,000 per µl
  • Produced by megakaryocytes stimulated by thrombopoietin.
  • Platelets circulate for an average of 9-10 days before removal by the spleen.
  • Participate in hemostasis/coagulation

White Blood Cells (Leukocytes)

Neutrophils (polymorphonuclear leucocytes)

  • Phagocytic
  • Compose approximately 56% of the white blood count
  • Chemotactic-directed phagocytic action in response to interleukin-1 from macrophages, histamine from basophils, mast cells, and platelets and complement proteins C3a and C5a in the plasma.

Eosinophils

  • Phagocytic & Cytotoxic
  • Compose approximately 4% of the white blood count.
  • Bind via C3b receptors resulting from parasitic alternative pathway complement activation.
  • Granules release proteins cytotoxic to parasites: MBP, peroxidase, arylsulphatase B, phospholipase D, and histaminase.

Basophils

  • Smallest granulocytes
  • Non-Phagocytic
  • Compose approximately 3% of the white blood count.
  • Involved in Type I hypersensitivity
  • Binding of IgE to the Fc receptors on basophils stimulates the release of histamine and heparin
  • Upon stimulation, basophils release TNF- and IL-4, which modulate endothelial adhesion molecules.
  • Basophils express integrins as receptors to the endothelial membrane proteins ICAM-1, ELAM-1and VCAM-1

Lymphocytes

  • Compose approximately 25% of the white blood count
  • Produced by the bone marrow.
  • Termed B cells when they achieve immune-competence within the marrow
  • Termed T cells when they achieve immune-competence within the thymus
  • B Cells respond to antigens by the production of antibodies, B and T cells produce lymphokines that control the immune response

Monocytes

  • Within approximately one day from being produced in the marrow, monocytes are transported to various organs where they become tissue macrophages via the influence of cytokines.
    • kidney - mesangial cells
    • bone - osteoclasts
    • liver - Kupfer cells
    • brain - microglia

Reference

1.
Lowe GD, Rumley A, Mackie IJ. 2004. Plasma fibrinogen. Annals of Clinical Biochemistry. 41(6):430-440. https://doi.org/10.1258/0004563042466884
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?